[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349075-105":59,"doc-detail-349075-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","extracellular-matrix-derived-mechanical-force-induces-cdk46-inhibitor-resistance-by-inhibiting-nek10-dependent-cell-cycle-regulation-in-breast-cancer","Extracellular matrix-derived mechanical force induces CDK4/6 inhibitor resistance by inhibiting NEK10 dependent cell cycle regulation in breast cancer","","Biomechanical signals from the extracellular matrix (ECM) drive tumor initiation and progression. This study evaluates how ECM-derived biomechanical signals mediate CDK4/6 inhibitor resistance in HR+, HER2− breast cancer. Using 3D Matrigel, collagen, and fibrin gels, single-cell sequencing from 23 patients, and TCGA data from 1092 cases, transcriptomics and Western blotting test the NEK10/p53/CDKN1A/CDK2 pathway. ECM forces suppress inhibitor-induced arrest and senescence, lower NEK10, and activate CDK2, enhancing resistance to Palbociclib in vivo with combined CDK4/6 and CDK2 inhibition restoring efficacy.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/extracellular-matrix-derived-mechanical-force-induces-cdk46-inhibitor-resistance-by-inhibiting-nek10-dependent-cell-cycle-regulation-in-breast-cancer/349075/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/extracellular-matrix-derived-mechanical-force-induces-cdk46-inhibitor-resistance-by-inhibiting-nek10-dependent-cell-cycle-regulation-in-breast-cancer/349075.png","ImageObject",300,407,{"name":92,"@type":93},"วิน","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the study?","Question",{"text":113,"@type":114},"To determine whether ECM-derived biomechanical signals mediate resistance to CDK4/6 inhibitors in HR+, HER2− breast cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the ECM mechanical signal modeled experimentally?",{"text":118,"@type":114},"The study used 3D Matrigel, collagen, and fibrin gels to examine how ECM-derived mechanical forces affect CDK4/6 inhibitor resistance.",{"name":120,"@type":111,"acceptedAnswer":121},"Which molecular pathway is implicated in the observed resistance?",{"text":122,"@type":114},"The mechanism centers on NEK10 regulation and the NEK10/p53/CDKN1A axis, coupled with activation of CDK2 signaling under ECM-induced mechanical force.",{"name":124,"@type":111,"acceptedAnswer":125},"What therapeutic strategy improved outcomes in NEK10-low tumors?",{"text":126,"@type":114},"Combined inhibition of CDK4/6 and CDK2 significantly improved therapeutic efficacy in NEK10-low breast cancer.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},349075,1790795929,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","Experimental Research  \nExtracellular matrix-derived mechanical force induces CDK4/6 inhibitor resistance by inhibiting NEK10 dependent cell cycle regulation in breast cancer  \nCong Li, MDa , Jian Wang, MDb,c , Yuming Jin, MDd , Yumeng Huang, MDe , Ruoxi Hong, MDa ,  \nDongshao Chen, MDa , Shaoyan Lin, MDa , Limin Chen, MDa , Huailiang Wu, MDa , Ting Du, MDf, Binghe Xu, MDg ,*, Wan Wang, MDh ,*, Shusen Wang, MDa ,*  \nBackground: Biomechanical signals play a pivotal role in tumor initiation and progression, with the extracellular matrix (ECM) acting as a key source of these signals. This study aims to investigate the role of ECM-derived biomechanical signals in mediating CDK4/6 inhibitor resistance in HR+, HER2− breast cancer.  \nMaterials and methods: This study utilized 3D Matrigel, collagen, and fibrin gels to examine the role of ECM-derived biomechanical signals in regulating CDK4/6 inhibitor resistance. Single-cell sequencing data from 23 breast cancer patients were analyzed to explore the core molecular mechanisms underlying this resistance. Transcriptomic analysis and Western blotting were conducted to assess the expression of the NEK10/p53/CDKN1A/CDK2 signaling pathway in breast cancers. Data from 1092 patients in TCGA were also incorporated, alongside a prognostic analysis of 25 clinical samples.  \nResults: ECM-derived biomechanical signals suppressed CDK4/6 inhibitor-induced cell cycle arrest and senescence in breast cancer cells, promoting drug resistance. scRNA-seq and tumor tissue analysis identified NEK10 as a key downregulated kinase associated with resistance. Mechanistically, ECM-induced mechanical forces reduced NEK10 expression via a cytoskeletondependent pathway, leading to suppression of the NEK10/p53/CDKN1A axis and activation of CDK2 signaling. NEK10-deficient cells and organoids displayed enhanced resistance to Palbociclib, which was reversed by co-treatment with the CDK2 inhibitor. In vivo , combined inhibition of CDK4/6 and CDK2 significantly improved therapeutic efficacy in NEK10-low breast cancer. Conclusion: This study underscores the critical role of ECM-derived biomechanical forces in regulating CDK4/6 inhibitor resistance in breast cancer and identifies NEK10 as a potential therapeutic target for improving breast cancer treatment. Keywords: biomechanical force, CDK4/6 inhibitor, cell cycle, extracellular matrix, NEK10  \nIntroduction  \nBreast cancer is the most commonly diagnosed cancer and the leading cause of cancer mortality among women worldwide. The estimated new cases reached 2.3 million in 2022, comprising 11.6% of all cancer cases, and 666 000 cases died of it[1] . In  \nrecent years, CDK4/6 inhibitors have emerged as a promising targeted therapy, demonstrating significant progress in the treatment of hormone receptor-positive and human epidermal growth factor receptor-2 negative (HR+/HER2−) advanced breast cancer[2] . These inhibitors primarily function by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), thereby  \naDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangdong, China, bDepartment of Oncology, Medical School of Tianjin University, Tianjin, China, cDepartment of General Surgery, Tianjin Fifth Central Horpital, Tianjin, China, dDepartment of Urology, Institute of Urology and National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China, eNeurology Department, University of Texas Medical Branch, Galveston, Texas, the United States, fNon-coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Department of Immunology, School of Basic Medical Sciences, Chengdu Medical College, Chengdu, China, gDepartment of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical  \nSciences and Peking Union Medical College, Beijing, China and h","cbCaicNfQGu7AHXD","https://ap.wps.com/l/cbCaicNfQGu7AHXD","pdf",5691779,15,"English","# Background\n# Materials and methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To determine whether ECM-derived biomechanical signals mediate resistance to CDK4/6 inhibitors in HR+, HER2− breast cancer.\"},{\"question\":\"How was the ECM mechanical signal modeled experimentally?\",\"answer\":\"The study used 3D Matrigel, collagen, and fibrin gels to examine how ECM-derived mechanical forces affect CDK4/6 inhibitor resistance.\"},{\"question\":\"Which molecular pathway is implicated in the observed resistance?\",\"answer\":\"The mechanism centers on NEK10 regulation and the NEK10/p53/CDKN1A axis, coupled with activation of CDK2 signaling under ECM-induced mechanical force.\"},{\"question\":\"What therapeutic strategy improved outcomes in NEK10-low tumors?\",\"answer\":\"Combined inhibition of CDK4/6 and CDK2 significantly improved therapeutic efficacy in NEK10-low breast cancer.\"}]","Extracellular matrix-derived mechanical force induces CDK4/6 inhibitor resistance by inhibiting NEK10 dependent cell cycle regulation in breast cancer | PDF",1790081516,38,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5641a64457a78beaf33a75613f3f2241.webp",983,1310,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2aac576e63b0cd1da0718eeab1681a59.webp",982,1309,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2554abd7c05cae2d80118ca9cffa2662.webp",981,1308,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/703419d2f71763befb7489220f802f9b.webp",980,1306]